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Abstract
To localize functionally significant domains in the amino acid transporters of mouse brain mEAAC1 and mASCT1, cRNA
encoding for wild-type and chimeric transporters was injected into Xenopus oocytes. Activity of expressed transporters was
investigated by measurements of uptake of 3H-labeled glutamate and serine and of glutamate- and serine-induced currents
under voltage clamp. Though all transporters accept glutamate and serine as substrate, the central part of the protein (Ala94-
Met418 of mEAAC1 and Ala119-Ile393 of mASCT1) determines substrate selectivity. The C-terminus rectifies the interaction
with the respective substrate. A channel mode of the glutamate transporter can be activated by glutamate and serine, and the
N- and C-termini of the mEAAC1 seem to be essential for the channel formation. ß 2000 Elsevier Science B.V. All rights
reserved.
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1. Introduction
The inwardly directed electrochemical gradient for
Na, which is maintained by the ATP-consuming
Na,K pump [1], serves as driving force for a large
variety of neurotransmitter transporters in nerve ter-
minals and glial cells. In a superfamily of acidic ami-
no acid transporters (for a review see [2]), the uptake
of substrate is not only coupled to the downhill
movement of Na, but also coupled to the counter
transport of K and co-transport of H [3]. A rep-
resentative of these transporters is the excitatory
amino acid carrier 1 (EAAC1, also named
EAAT3), which accepts glutamate as a common sub-
strate. The transporters of the ASC family that com-
monly accept alanine, serine and cysteine, therefore
named ASC, have about 40% identity in amino acid
sequence with the glutamate transporters, and hence
are assumed to belong to the same superfamily with
putative 8^10 transmembrane domains.
For EAAC1, it has been proposed that the trans-
port of one glutamate is coupled to the co-transport
of 2 or 3 Na ions [3,4]. As a consequence, 1 or 2
positive net charges are translocated across the mem-
brane per transport cycle generating an inward-di-
rected current. In electrophysiological experiments,
it has been shown that the transporter indeed gener-
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ates substrate-activated currents, but evidence has
accumulated that this only in part results from the
unbalanced charge movements and in part also orig-
inates from a ‘channel mode’ [5]. This mode of the
transporter allows ion passage without being coupled
to substrate translocation, most likely through a Cl3-
permeable channel (see e.g. [6,7]). For ASCT1, an
electroneutral amino acid exchange mode coupled
to the translocation of one Na has been suggested
[8] that does not depend on K ; a small alanine-
induced current has been attributed to an uncoupled
£ow of Cl3.
EAAC1 and ASCT1 share more than 40% of iden-
tity in their amino acid sequence and have nearly
70% of similarity (compare Fig. 1A for the trans-
porters of mouse brain [9,10]). Hence, it is not sur-
prising that ASCT1 to some extent also transports
glutamate, and EAAC1, e.g. serine. Nevertheless,
there are clear di¡erences in sensitivity to these two
substrates and in the current signals (see also [2,7]).
To localize domains that are functionally signi¢cant,
we constructed chimeras between EAAC1 and
ASCT1 of mouse brain (see also [11]) and measured
substrate uptake and substrate-induced current after
expression in Xenopus oocytes.
2. Materials and methods
2.1. Construction of chimeras
Chimeric transporters were constructed from
mEAAC1 and mASCT1 using recombinant PCR
(compare Fig. 1B), where N- or C-terminal parts
were from mEAAC1 (chimeras 1 and 4) with the
remainder from mASCT1, and vice versa (chimeras
2 and 3). After checking the sequences, chimeras
were cloned into the PNWP vector, which was modi-
¢ed from PNSK2, and has the polyA tail and ribo-
some binding sites of Xenopus oocytes to ensure high
transcription in vitro and expression in the oocytes.
The following primers were used (bold letters indi-
cate homologous sequence sections):
For chimera 1
For chimera 2
For chimera 3
For chimera 4
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2.2. Oocytes and cRNA injection
To obtain the oocytes for injection of the respec-
tive cRNAs, females of the clawed toad Xenopus lae-
vis were anesthetized with tricaine (MS222, Sandoz,
Basle (Switzerland) 1 g/l). Parts of the ovary were
dissected and treated with collagenase (1.5^3 mg/
ml) to remove follicular cells. Full-grown prophase-
arrested oocytes were selected for experiments. For
expression of transporters, oocytes were injected with
50 nl cRNA for wild-type or chimeric proteins (1 ng/
nl). The cells were stored at 19‡C in oocyte Ringer’s
solution (ORi, see below) containing antibiotics (in
mg/l: 70 gentamicin or 25 streptomycin plus 20 pen-
icillin). Experiments were performed at room temper-
ature (22‡C) after 1^5 days of incubation.
2.3. Western blot
Yolk-free homogenates of oocytes were prepared
as described by Vasilets [12] 3 days after injecting
cRNA, and by passing the oocytes through 200-Wl
Eppendorf pipette tips in homogenization bu¡er
(HBO, see solution). Twenty-microliter aliquots of
yolk-free homogenates were electrophoresced on
PAGE gels. Proteins from non-stained gels were elec-
trophoretically transferred on nitrocellulose mem-
brane for a Western blot (overnight at room temper-
ature, 0.4 mA/cm2). The preparations expressing
mEAAC1, chimera 2 and chimera 4 were immunos-
tained with anti-mEAAC1 C-terminus (462^523 aa)
antibody, and mASCT1, chimera1 and chimera3
with anti-mASCT1 C-terminus (475^532 aa) anti-
body as the primary antibodies (prepared by Shang-
hai Institute of Cell Biology, Chinese Academy of
Sciences), and visualized by the secondary alkaline-
phosphatase conjugated antibody (Promega).
2.4. Flux measurements
To determine the maximum transport activity, up-
take by single oocytes of 3H-labeled glutamate or
serine (Amersham, Braunschweig) was measured at
90 mM external Na and 1 mM total concentration
of the respective substrate. Oocytes (about 10 each)
were incubated for 20 min in a ORi solution (volume
200 Wl) containing 1 mM cold and 15 nM 3H-labeled
substrate (9.25 kBq/200 Wl). To determine unspeci¢c
uptake, some measurements were performed in Na-
free incubation solution. The rate of uptake was sim-
ilar to that of oocytes not injected with cRNA.
Therefore, the uptake of non-injected control oocytes
was normally used for subtraction of the back-
ground. To exclude oocytes with high membrane
leakage, 1 mM sucrose with 18 WM [14C]sucrose (16
kBq/200 Wl, Du Pont NEN, Bad Homburg) was
added to the incubation medium (see [13]).
2.5. Electrophysiology
The electrophysiological experiments were per-
formed with conventional two-electrode voltage
clamp (TEVC) (see [14]). For characterization of
transporter-mediated current, steady-state membrane
currents were recorded at the end of 200-ms, rectan-
gular voltage-clamp pulses (from 3150 to +30 mV in
10-mV increments) that were applied from a holding
potential of 360 mV, and voltage dependencies of
steady-state membrane currents were obtained. The
transporter-mediated current was determined as the
current that can be activated by glutamate or serine.
2.6. Solutions
The standard ORi solution had the following com-
position (in mM): 90 NaCl, 2 KCl, 2 MgCl2, 5
MOPS (adjusted to pH 7.4 with Tris). In the Na-
free solution NaCl was replaced by tetramethylam-
monium chloride. The HBO contained (in mM):
Tris^HCl 20 (pH 7.4), MgCl2 5, NaH2PO4 5,
EDTA 1, NaCl 100, KCl 10, DTT 1 and PMSF 1
and 5Wg/ml of each of leupeptin, pepstatin and anti-
pain.
3. Results
To localize functionally signi¢cant domains, chi-
meras between mEAAC1 and mASCT1 were con-
structed, where the center parts of wild-type (Ala94-
Met418 and Ala119-Ile393, respectively) were combined
with the N- and/or C-terminal sections of the other
transporter (see Fig. 1A,B). Function was investi-
gated by measurements of uptake of glutamate and
serine and by measurements of substrate-activated
currents.
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3.1. Uptake measurements
To test functional expression of wild-type and chi-
meric transporters in the oocytes, uptake of 3H-la-
beled glutamate and serine was measured in cRNA-
injected and non-injected control oocytes applying
saturating concentrations of 1 mM, which gave sim-
ilar uptake rates as 0.5 mM. Interestingly, in contrast
to the activation of uptake, 1 mM is not su⁄cient for
maximum activation of transporter-mediated cur-
rents (see below). The uptake rates, nevertheless, dif-
fered considerably (Fig. 2) though the Western blots
show (Fig. 1C) that all transporters were expressed
to about the same extent. The data for uptake were
normalized to the rate of glutamate uptake by
mEAAC1, which corresponds to 741 þ 43 fmol/s;
the rate of serine uptake by mASCT1 corresponds
to 540 þ 47 fmol/s. The relative rates of uptake, cor-
rected for unspeci¢c uptake, are summarized in the
¢rst rows of Tables 1 and 2, respectively. As ex-
pected, mEAAC1 shows highest uptake for gluta-
mate, mASCT1 for serine. Glutamate is also well
accepted by chimera 2 and, though to a smaller ex-
tent, by chimera 3. Glutamate is also transported by
mASCT1 and chimeras 1 and 4, but at an even fur-
ther reduced rate (Fig. 2A and Table 1). In turn,
serine is well accepted by mASCT1 and chimeras 1
and 4 while mEAAC1 and chimeras 2 and 3 trans-
port serine at an e⁄cacy of only about 40% com-
pared to mASCT1 (see Fig. 2B and Table 2).
Fig. 1. (A) Alignment of amino acid sequence of mEAAC1 and mASCT1. The dashes indicate identical amino acids. The gray under-
laid sections represent putative transmembrane domains according to [9,20]. (B) Chimeric patterns of transporters and principle of
their construction. (C) Western blots.
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3.2. Voltage-clamp experiments
Glutamate transport by EAAC1 involves unbal-
anced charge movements, and hence, is electrogenic.
Assuming that one positive net charge is transported
into the cell per one glutamate, a current of 370 nA
can be expected from the rate of glutamate uptake
(see Table 1). In the oocytes with expressed
mEAAC1, 1 mM glutamate can induce a current of
even several WA (see Fig. 3), which supports the view
of an uncoupled channel mode that exceeds the elec-
trogenicity of the transport mode by more than one
order of magnitude. A reversal potential for the di-
rection of the current could not be detected up to
+30 mV, but this is in line with the ¢ndings for the
EAAC1 of rat [15] and the human EAAT3 [16]. On
this scale of transmitter-mediated current, mASCT1
and the chimeras do not generate any signi¢cant
current in response to glutamate. But at higher res-
olution (see inset in Fig. 3A) transporter-mediated
steady-state currents can clearly be resolved. Partic-
ularly chimeras 2 and 3, and to some extent also
chimera 1, exhibit currents (for 3100 mV see Table
1). For better comparison with the currents expected
from the £ux measurements, Table 2 also lists the
currents measured at 340 mV, which is close to
the resting potential of the oocytes. These measured
currents activated by glutamate are in the range one
would expect for the electrogenic transport mode. At
least there seems to be no major contribution from a
channel mode in mASCT1 and the chimeras as seen
for mEAAC1.
Also the currents activated by serine in mASCT1
and the chimeras are smaller than or within the
range expected for electrogenic transporters. Interest-
ingly, serine as the substrate for mASCT1 (Fig. 2)
could activate a pronounced current signal in
mEAAC1 of several hundred nA (Table 2). All the
other transporters produce at 340 mV negligible cur-
rent. Nevertheless, at 3100 mV, signals of inward
current can clearly be detected; at potentials less
negative than 340 mV the current reverses direction
indicating that it is mediated by a channel mode [3].
The dependency of transporter-mediated current
on substrate concentration was measured at di¡erent
membrane potentials ; the estimated concentrations
Fig. 1 (continued).
Table 1
Characteristics of glutamate-activated transport by wild-type and chimeric transporters
mEAAC1 mASCT1 Chimera 1 Chimera 2 Chimera 3 Chimera 4
Flux (normalized) 1 0.19 0.13 0.80 0.56 0.25
Expected current (nA) 370 313 39 356 339 318
Current (nA) (at 3100/340 mV, and 1 mM) 32558/3747 310/36 345/318 367/320 388/331 319/ns
K1=2 (mM) (at 3100 mV) 0.25 1.25 0.24 0.20 2.05 0.71
Expected currents were determined from rate of glutamate uptake on the basis of one net charge being transported per glutamate. ns,
no signi¢cant current detectable. K1=2 values are for current activation by glutamate according to Eq. 1 given in the legend to Fig. 4.
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for half-maximum stimulation were voltage-inde-
pendent. This is in line with the observation for
EAAC1 of rat which has a K1=2 value for glutamate
that is voltage-dependent only for non-saturating
Na concentrations [15] though the values we found
for mEAAC1 are by a factor of about 5 larger. As an
example, Fig. 4A and B show the dependencies at
3100 mV for current stimulation by glutamate and
serine, respectively. The data for dependency on glu-
tamate concentration could be ¢tted with a Hill co-
e⁄cient of n = 1, while for serine a Hill coe⁄cient of
n = 2 was used for the ¢ts. This was independent of
the transporter studied. The corresponding K1=2 val-
ues are listed in Tables 1 and 2. These values are all
much higher than those found for stimulation of up-
take, which are in the range of tens of WM for
EAAC1 and ASCT1 [17]. Also in our £ux measure-
ments, we found a K1=2 value of about 30 WM for
stimulation of mEAAC1 by glutamate, and all the
transporters show maximum rate of uptake at 500
WM.
4. Discussion
mEAAC1 and mASCT1 expressed in Xenopus oo-
cytes both transport at a high rate glutamate and
serine. Glutamate is favored by mEAAC1 with an
uptake rate of more than 700 fmol/s, serine by
mASCT1 with an uptake rate of about 550 fmol/s.
These values are by a factor of about 5 higher than
what we found previously for the GABA transporter
Fig. 2. Uptake of 3H-labeled glutamate (A) or serine (B) by mEAAC1, mASCT1 and the chimeric transporters in comparison to non-
injected control oocytes. Total concentration of neurotransmitters in the incubation medium was 1 mM. The horizontal lines represent
unspeci¢c uptake, which corresponds to the uptake seen in non-injected control oocytes. Data are normalized to glutamate uptake by
EAAC1 and are averages þ S.E.M., numbers of oocytes are given above each column.
Table 2
Characteristics of serine-activated transport by wild-type and chimeric transporters
mEAAC1 mASCT1 Chimera 1 Chimera 2 Chimera 3 Chimera 4
Flux (normalized) 0.48 1 0.83 0.35 0.47 0.63
Expected current (nA) 325 352 343 318 324 333
Current (nA) (at 3100/340 mV, and 1 mM) 3643/3203 319/ns 3113/317 332/312 328/ns 3159/ns
K1=2 (mM) (at 3100 mV) 1.35 1.37 1.06 1.35 1.96 1.53
Expected currents were determined from rate of serine uptake on the basis of one net charge being transported per serine. ns, no sig-
ni¢cant inward current detectable. K1=2 values are for current activation by serine according to Eq. 1 given in the legend to Fig. 4.
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GAT1, which was expressed at a density of about
2U1011 transporters per oocyte [18] corresponding
to about 10,000 per Wm2. The non-common sub-
strates, glutamate for mASCT1 and serine for
mEAAC1, are transported at rates of 140 and 260
fmol/s, respectively. Western blots indicate similar
degree of expression of the transporters, but it is of
course hard to judge whether the di¡erences in rate
of uptake between di¡erent transporters result from
di¡erences in the transport rate of a transport mol-
ecule or in number of transporters targeted to the
oocyte membrane (compare e.g. [19]).
Glutamate induces in mEAAC1 huge currents that
are too large to be assigned to pure electrogenic
transport, and the existence of channel mode has
been proposed (see e.g. [7]). Comparison of the cur-
rents expected from translocation of 1 or 2 charges
per glutamate with the currents detected at 340 mV
yields that the measured currents are by a factor of 5
to 10 larger (see Table 1). We made a similar obser-
vation with activation of mEAAC1 by serine (Table
2). Though the inward currents reach several hun-
dred nA at the negative potentials, no reversal po-
tential could be detected within the covered potential
Fig. 3. Voltage dependence of current activated by 1 mM glutamate (A) or serine (B) mediated by mEAAC1, mASCT1 and the chi-
meric transporters. Data are averages from 3^5 oocytes ( þ S.E.M.). In the inset in A, the data for mASCT1 and the chimera are re-
drawn at a higher current resolution, in B, the data for mASCT1 and chimeras 1 and 4.
Fig. 4. Dependence of substrate-activated current on glutamate (A) and serine concentration (B) at 3100 mV. Data are normalized to
saturate at Imax = 1 and are averages from 3 to 5 oocytes ( þ S.E.M.). Solid lines are ¢ts of
I  Imax S
n
Sn Kn1=2
1
to the data with n = 1 in A and n = 2 in B.
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range up to +30 mV, but it was shown by others [6]
that a reversal potential can be detected under opti-
mized ionic conditions and the changes of the rever-
sal potential with external Cl3 follow Nernst depend-
ency. The absence of a reversal potential could be
due to an inward-rectifying gating mechanism, and
that the current at only slightly negative and at pos-
itive potentials is governed by the normal transport
mode. For the formation of the channel mode, the
entire mEAAC1 protein seems to be essential since
all the other transporters, mASCT1 and the chime-
ras, generate currents that are similar to or even less
than the currents expected from pure electrogenic
substrate transport. Serine is nearly as e¡ective as
glutamate in activation of this channel mode in
mEAAC1.
An uncoupled electric current is also associated
with the ASCT1, which has a reversal potential close
to the equilibrium potential for Cl3 [8]. Though the
serine-activated currents are small, a reversal at po-
tentials of about 330 mV can clearly be detected
(Fig. 3). It was suggested that this current is carried
by Cl3 and mediated by a channel mode or an en-
dogenous channel coupled to the transporter (see e.g.
[20]); in its transport mode ASCT1 operates in an
electrically silent exchange mode and does not con-
tribute to the electrical signal. The channel mode of
mASCT1 must have a di¡erent molecular basis than
the channel mode in EAAC1 since it can also be
detected in the chimeras 1 and 4 (inset Fig. 3B),
but the current can only be activated by serine not
by glutamate. While for the formation of the
EAAC1-channel mode the presence of the N- and
C-terminal domains in the mEAAC1 protein are nec-
essary, the ASCT1-channel mode can still be formed
if either the N- or the C-terminus of the mASCT1
protein are replaced by the corresponding domains
of mEAAC1. Whether N- and C- terminal domains
are su⁄cient for EAAC1-channel formation needs
further investigations that are under progress.
Another manifestation of channel and transport
modes in the two amino acid transporters are the
di¡erent dependencies of uptake and current on sub-
strate concentration (see Tables 1 and 2). While rate
of glutamate and serine uptake are saturated at
1 mM, K1=2 values for activation of the current are
in the range of 1 mM. Only mEAAC1 and chimeras
1 and 2 exhibit K1=2 values of about 200 WM, which
is, nevertheless, by a factor of 5 higher than the K1=2
values for activation of glutamate uptake. This may
re£ect di¡erent sensitivities for the substrate of trans-
port and channel mode.
Both wild-type and the chimeric transporters ac-
cept glutamate as well as serine as substrate, but
transport occurs at di¡erent rates. Glutamate is
transported by mEAAC1 and chimera 2 at compa-
rably high rate, and slightly less by chimera 3 (Table
1). They all have in common the central part of the
EAAC1 protein (Fig. 1) and it seems that the C-
terminal domain of mEAAC1 stabilizes the sensitiv-
ity for glutamate. The center domain between residue
331 and 411 (numbering of mEAAC1) shows a high
degree of identity conserved. In the glutamate trans-
porter family, Glu373 and Tyr372 (Glu404 and Tyr403
in EAAT2 of rat) are conserved, but are not present
in ASCT1. It has been suggested that these residues
are located in the vicinity of the substrate-transloca-
tion pathway [21,22], and a pore loop-like structure
has been recognized [23]. N- and C-termini are not
essential for substrate recognition with respect to
uptake as well as current stimulation, but the pres-
ence of the C-terminus improves substrate transport.
Serine is transported at comparably high rate by
mASCT1 and chimera 1 and slightly less by chimera
4 (Table 2). In analogy to the transporters of gluta-
mate, the transporters for serine share the central
part of mASCT1 (Fig. 1), and the C-terminal domain
of mASCT1 seems to stabilize the sensitivity for ser-
ine.
5. Conclusion
Though all the investigated wild-type and chimeric
transporters accept glutamate as well as serine as
substrate, the central part is essential for the discrim-
ination between glutamate and serine. The C-termi-
nus of EAAC1 supports the a⁄nity for glutamate
and of ASCT1 for serine. Activation of mEAAC1
and mASCT1 leads to a current component un-
coupled from the transport mode that seems to
have di¡erent molecular basis. Activation of the
EAAC1-type channel mode needs the presence of
both the N- and C-terminus of EAAC1.
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